[HTML][HTML] Evidence-based pharmacological treatment options for ADHD in children and adolescents
K Mechler, T Banaschewski, S Hohmann… - Pharmacology & …, 2022 - Elsevier
Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder
characterized by inattention, hyperactivity, and impulsivity, causing functional impairment. Its …
characterized by inattention, hyperactivity, and impulsivity, causing functional impairment. Its …
Evidence-based pharmacological treatment options for ADHD in children and adolescents.
K Mechler, T Banaschewski, S Hohmann… - Pharmacology & …, 2021 - europepmc.org
Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder
characterized by inattention, hyperactivity, and impulsivity, causing functional impairment. Its …
characterized by inattention, hyperactivity, and impulsivity, causing functional impairment. Its …
Evidence-based pharmacological treatment options for ADHD in children and adolescents
K Mechler, T Banaschewski… - Pharmacology & …, 2022 - pubmed.ncbi.nlm.nih.gov
Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder
characterized by inattention, hyperactivity, and impulsivity, causing functional impairment. Its …
characterized by inattention, hyperactivity, and impulsivity, causing functional impairment. Its …